128 related articles for article (PubMed ID: 6975158)
41. Lymphoblastic lymphoma/leukemia with convoluted nuclei: the question of its relation to the T-cell lineage studied in 13 patients.
Boucheix C; Diebold J; Bernadou A; Reynes M; Tulliez M; Cadiou M; Paczynski V; Capron F; Bilski-Pasquier G
Cancer; 1980 Apr; 45(7):1569-77. PubMed ID: 6966181
[TBL] [Abstract][Full Text] [Related]
42. Adult non-Hodgkin's lymphoma. Correlation of cell surface marker phenotype with prognosis, the new working formulation, and the Rappaport and Lukes-Collins histomorphologic schemes.
Rudders RA; DeLellis RA; Ahl ET; Bernstein S; Begg CB
Cancer; 1983 Dec; 52(12):2289-99. PubMed ID: 6640501
[TBL] [Abstract][Full Text] [Related]
43. An immunohistological study of immunoglobulin content of primary central nervous system lymphomas.
Taylor CR; Russell R; Lukes RJ; Davis RL
Cancer; 1978 Jun; 41(6):2197-205. PubMed ID: 418869
[TBL] [Abstract][Full Text] [Related]
44. Immunologic basis for the redefinition of malignant lymphomas.
Parker JW
Am J Clin Pathol; 1979 Oct; 72(4 Suppl):670-86. PubMed ID: 386778
[TBL] [Abstract][Full Text] [Related]
45. Extranodal oral lymphoma. Part II. Relationships between clinical features and the Lukes-Collins classification of 34 cases.
Howell RE; Handlers JP; Abrams AM; Melrose RJ
Oral Surg Oral Med Oral Pathol; 1987 Nov; 64(5):597-602. PubMed ID: 3499589
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
Brouet JC; Labaume S; Seligmann M
Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
[TBL] [Abstract][Full Text] [Related]
47. Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.
Wright D; McKeever P; Carter R
J Clin Pathol; 1997 Feb; 50(2):128-34. PubMed ID: 9155693
[TBL] [Abstract][Full Text] [Related]
48. Lymphocyte markers in non-Hodgkin's lymphomas.
Payne SV; Smith JL; Jones DB; Wright DH
Br J Cancer; 1977 Jul; 36(1):57-64. PubMed ID: 329850
[TBL] [Abstract][Full Text] [Related]
49. Concordance of the Kiel and Lukes-Collins classifications of non-Hodgkin's lymphomas.
Lennert K; Collins RD; Lukes RJ
Histopathology; 1983 Jul; 7(4):549-59. PubMed ID: 6604012
[TBL] [Abstract][Full Text] [Related]
50. Immunologic markers for classification of leukemias and non-Hodgkin lymphomas.
Thierfelder S; Rodt H; Thiel E; Hoffmann-Fezer G; Netzel B; Haas RJ; Wündisch GF; Bender-Götze C
Recent Results Cancer Res; 1979; 69():41-8. PubMed ID: 382307
[No Abstract] [Full Text] [Related]
51. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
52. Immunological evaluation of 15 children with non-Hodgkin lymphoma.
Rosanda-Vadalà C; De Bernardi B; Pasino M; Tonini GP; Comelli A; Mori PG; Perutelli P; Massimo L
Haematol Blood Transfus; 1977; 20():221-6. PubMed ID: 580250
[TBL] [Abstract][Full Text] [Related]
53. Lymphoblastic lymphoma/leukemia of T-cell origin: ultrastructural, cytochemical, and immunologic features of ten cases.
Navas Palacios JJ; Valdes MD; Pallares MA; Gomez de Salazar MD; Garcia Marcilla A
Cancer; 1981 Nov; 48(9):1982-91. PubMed ID: 6975156
[TBL] [Abstract][Full Text] [Related]
54. Small noncleaved follicular center cell lymphoma: Burkitt's and non-Burkitt's variants in the US. II. Pathologic and immunologic features.
Pavlova Z; Parker JW; Taylor CR; Levine AM; Feinstein DI; Lukes RJ
Cancer; 1987 Jun; 59(11):1892-902. PubMed ID: 2436741
[TBL] [Abstract][Full Text] [Related]
55. Morphologic and immunologic evidence of composite B- and T-cell lymphomas. A report of three cases developing in follicular center cell lymphomas.
York JC; Cousar JB; Glick AD; Flexner JM; Stein R; Collins RD
Am J Clin Pathol; 1985 Jul; 84(1):35-43. PubMed ID: 3874537
[TBL] [Abstract][Full Text] [Related]
56. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T
Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
[TBL] [Abstract][Full Text] [Related]
57. Surface markers in leukemias and lymphomas.
Siegal FP; Filippa DA; Koziner B
Am J Pathol; 1978 Feb; 90(2):451-60. PubMed ID: 304673
[TBL] [Abstract][Full Text] [Related]
58. Diversity of immunological phenotypes of lymphoblastic lymphoma.
Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
[TBL] [Abstract][Full Text] [Related]
59. [Introduction to the modern classifications of the non-Hodgkin malignant lymphomas (author's transl)].
Heimann R; Van den Heule B
Dermatologica; 1978; 157(6):345-56. PubMed ID: 309837
[TBL] [Abstract][Full Text] [Related]
60. Studies with multiple markers on malignant lymphomas and lymphoid leukemias.
Watanabe S; Shimosato Y; Shimoyama M; Minato K
Cancer; 1982 Dec; 50(11):2372-82. PubMed ID: 6982748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
